CapitalM ZoomCast Live – COVID Series — A Discussion with Jim Hughes: Advancing UMB-Born Technologies in the Fight Against COVID-19 & Beyond

Marty Rosendale’s guest, Jim Hughes, Senior Vice President and Chief Enterprise & Economic Development Officer at University of Maryland, Baltimore shared how university physicians, faculty/researchers and tech transfer professionals are working to bring innovations to life to help clinicians on the front line treat patients and fight COVID-19. Watch here » | Listen here »

UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System

Company spun out of University of Maryland School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients BALTIMORE, May 7, 2020 /PRNewswire/ — Pumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights […]

Technical.ly Baltimore: UMB-born medical device company Breethe acquired by Abiomed

The Halethorpe-based company’s lung-like technology will become part of the product portfolio of Massachusetts’ Abiomed. Breethe, the medical device company founded by renowned University of Maryland School of Medicine surgeon and professor Dr. Bartley Griffith, has been acquired by Danvers, Massachusetts-based Abiomed, the companies announced this week. Breethe’s system, which is designed to behave like a human lung, will […]

UM Ventures Backs Innovative UMB Startup Programs and Technologies to Aid Clinicians in the Fight Against COVID-19 Pandemic

Following the initial outbreak of coronavirus (COVID-19) in the US, most of the public’s attention was focused on finding hand sanitizer, toilet paper and face masks. While these resources are imperative to help prevent the spread of the virus, there is a dire need for more healthcare technology that will directly impact the treatment of […]

BioProcess International: Allogene turns to MaxCyte’s tech for its off-the-shelf CAR-T therapies

MaxCyte says its clinically validated electroporation technology will help increase efficiency and improve yield of Allogene’s allogeneic CAR-T therapy candidates. Pfizer-backed biotech Allogene launched in 2018 with a focus on developing allogeneic, or off-the-shelf, chimeric antigen receptor (CAR) T-cell therapies. To achieve this, the firm has regularly stressed the importance of manufacturing, devoting “considerable time and resources” to […]

BioBuzz: Rachel King of GlycoMimetics Among 12 Women Who Have Shaped the History of the BioHealth Capital Region

Rachel 2018-09-28 Glycomimetics retouch-2-2

The BioHealth Capital Region (BHCR) and its life science ecosystem have a rich and deep history of pioneering scientific innovation, research, development, and commercialization. The region’s history has been written by life science anchor companies, scientific research universities, government research organizations, rich startup culture, and serial entrepreneurs, all of whom have played critical roles in […]

MaxCyte and Allogene Therapeutics Sign Clinical and Commercial License Agreement to Enable the Advancement of Allogeneic CAR T (AlloCAR T™) Therapies

Agreement enables Allogene, a pioneer in the development of AlloCAR T™ therapies for cancer, to utilize MaxCyte’s ExPERT™ platform in target candidates GAITHERSBURG, MD, and SOUTH SAN FRANCISCO, CA, March 24, 2020 – MaxCyte, Inc., a global cell-based therapies and life sciences company, and Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development […]

BioSpace: Maryland Booms in the BioCapital Hotbed

As the BioCapital Hotbed continues to grow, the state of Maryland is seeing a boom in life sciences employment as multiple companies build out manufacturing facilities in the state. Last year, Kite Pharma, a subsidiary of Gilead Sciences, broke ground on their Frederick, Maryland facility that will significantly expand the company’s ability to manufacture a variety of CAR-T therapies, […]

BioBuzz: MaxCyte's Jim Brady Among Gene Editing Experts Who Gathered to Discuss Transformative Potential of CRISPR on Genomic Medicine

Montgomery College’s Bioscience Education Center (BEC) is the place to be, to see and to hear from some of the brightest life science minds in BioHealth Capital Region (BHCR). Home to the region’s most important biotech workforce development and training programs, including; Bio-Trac, the graduate/post-graduate level program offering hands-on laboratory training workshops for research scientists, BioTrain, the incumbent worker […]

Maryland Tech Council Expands to Frederick to Create Larger Footprint in State of Maryland

– Forming Workforce Coalition in Frederick to address issues tied to attracting and retaining human capital – Coordinating with Universities at Shady Grove to establish its Montgomery County offices – Launched “We are Here” Campaign to Emphasize Reach and Impact Throughout the State FREDERICK, Md.–(BUSINESS WIRE)–The Maryland Tech Council (MTC) announced today it has expanded its offices to Frederick to broaden […]

PressComm

News